EVALUATING THE RISKS OF WITHDRAWAL SYMPTOMS AND REBOUND INSOMNIA UPON DISCONTINUATION OF DARIDOREXANT IN PATIENTS WITH INSOMNIA DISORDER

被引：0
|
作者：
Leger, D. [1 ]
Fietze, I. [2 ]
Pain, S. [3 ]
Kinter, D. Seboek [3 ]
Flamion, B. [3 ]
Mignot, E. [4 ]
机构：
[1] Univ Paris 05, AP HP, Paris, France
[2] Univ Hosp, Ctr Sleep Med, Charit, Berlin, Germany
[3] Idorsia Pharmaceut Ltd, Allschwil, Switzerland
[4] Stanford Med, Ctr Narcolepsy, Palo Alto, CA USA
来源：
SLEEP MEDICINE | 2022年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [1] Risks of Withdrawal Symptoms and Rebound Insomnia after Discontinuation of Daridorexant in Patients with Insomnia
    Kinter, Dalma Seboek
    Leger, Damien
    Fietze, Ingo
    Pain, Scott
    Flamion, Bruno
    Mignot, Emmanuel
    INTERNIST, 2022, 63 (SUPPL 3): : 320 - 321
  • [2] ABSENCE OF WITHDRAWAL SYMPTOMS AND REBOUND INSOMNIA UPON DISCONTINUATION OF DARIDOREXANT IN PATIENTS WITH INSOMNIA
    Leger, Damien
    Fietze, Ingo
    Pain, Scott
    Kinter, Dalma Seboek
    Flamion, Bruno
    Mignot, Emmanuel
    SLEEP, 2021, 44 : A139 - A139
  • [3] Daridorexant for insomnia disorder
    Spiegelhalder, Kai
    Feige, Bernd
    Riemann, Dieter
    Kyle, Simon D.
    LANCET NEUROLOGY, 2022, 21 (02): : 104 - 105
  • [4] REBOUND INSOMNIA IN NORMALS AND PATIENTS WITH INSOMNIA AFTER ABRUPT AND TAPERED DISCONTINUATION
    ROEHRS, T
    MERLOTTI, L
    ZORICK, F
    ROTH, T
    PSYCHOPHARMACOLOGY, 1992, 108 (1-2) : 67 - 71
  • [5] BENZODIAZEPINE WITHDRAWAL AND REBOUND INSOMNIA
    MORGAN, K
    TOMENY, M
    ACTA PSYCHIATRICA SCANDINAVICA, 1989, 80 (03) : 297 - 298
  • [6] BENZODIAZEPINE WITHDRAWAL AND REBOUND INSOMNIA - REPLY
    SCHNEIDERHELMERT, D
    ACTA PSYCHIATRICA SCANDINAVICA, 1989, 80 (03) : 298 - 298
  • [7] "Rebound" is not an appropriate criterion for withdrawal insomnia
    Kripke, Daniel F.
    SLEEP MEDICINE, 2014, 15 (12) : 1594 - 1594
  • [8] Daridorexant in Insomnia Disorder: A Profile of Its Use
    Tina Nie
    Hannah A. Blair
    CNS Drugs, 2023, 37 : 267 - 274
  • [9] Daridorexant for the treatment of insomnia disorder: findings and implications
    Jéssica Barreto Ribeiro dos Santos
    Michael Ruberson Ribeiro da Silva
    European Journal of Clinical Pharmacology, 2022, 78 : 1749 - 1761
  • [10] Daridorexant for the treatment of insomnia disorder: findings and implications
    Ribeiro dos Santos, Jessica Barreto
    Ribeiro da Silva, Michael Ruberson
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (11) : 1749 - 1761
12345